Multicriteria-Based Ranking Model for Risk Management of Animal Drug Residues in Milk and Milk Products; Extension of Comment Period, 45540-45541 [2015-18668]

Download as PDF 45540 Federal Register / Vol. 80, No. 146 / Thursday, July 30, 2015 / Notices The Agency will consider public comments on the settlement until August 31, 2015. The Agency will consider all comments received and may modify or withdraw its consent to the settlement if comments received disclose facts or considerations which indicate that the amended settlement is inappropriate, improper, or inadequate. ADDRESSES: Copies of the settlement are available from the Agency by contacting Ms. Paula V. Painter, Environmental Protection Specialist using the contact information provided in this notice. Comments may also be submitted by referencing the Site’s name through one of the following methods: • Internet: www.epa.gov/region4/ superfund/programs/enforcement/ enforcement.html. • U.S. Mail: U.S. Environmental Protection Agency, Superfund Division, Attn: Paula V. Painter, 61 Forsyth Street SW., Atlanta, Georgia 30303. • Email: Painter.Paula@epa.gov. FOR FURTHER INFORMATION CONTACT: Paula V. Painter at (404) 562–8887. DATES: review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0275. The approval expires on July 31, 2018. A copy of the supporting statement for this information collection is available on the Internet at http:// www.reginfo.gov/public/do/PRAMain. Dated: July 24, 2015. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2015–18649 Filed 7–29–15; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2015–N–1305] Dated: June 9, 2015. Anita L. Davis, Chief, Enforcement and Community Engagement Branch, Superfund Division. Multicriteria-Based Ranking Model for Risk Management of Animal Drug Residues in Milk and Milk Products; Extension of Comment Period [FR Doc. 2015–18727 Filed 7–29–15; 8:45 am] AGENCY: BILLING CODE 6560–50–P HHS. ACTION: [Docket No. FDA–2008–N–0397] Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; State Enforcement Notifications Food and Drug Administration, HHS. Notice. The Food and Drug Administration (FDA) is announcing that a collection of information entitled, ‘‘State Enforcement Notifications’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE–14526, Silver Spring, MD 20993–0002, PRAStaff@ fda.hhs.gov. Lhorne on DSK7TPTVN1PROD with NOTICES SUMMARY: On June 8, 2015, the Agency submitted a proposed collection of information entitled, ‘‘State Enforcement Notifications’’ to OMB for SUPPLEMENTARY INFORMATION: VerDate Sep<11>2014 14:54 Jul 29, 2015 Jkt 235001 The Food and Drug Administration (FDA or we) is extending the comment period for the risk assessment entitled ‘‘MulticriteriaBased Ranking Model for Risk Management of Animal Drug Residues in Milk and Milk Products.’’ A notice of the availability of the risk assessment and our request for comments appeared in the Federal Register of April 30, 2015. We initially established July 29, 2015, as the deadline for the submission of requested comments that can help improve the ranking model approach, including the specific criteria, scoring, and weighting scheme; the scientific data and assumptions used to inform scoring used in the model; the selection of animal drugs evaluated; and the clarity and the transparency of the risk assessment. We are taking this action in response to a request for an extension to allow interested persons additional time to submit comments. DATES: FDA is extending the comment period on the risk assessment whose availability we announced in a notice published on April 30, 2015 (80 FR 24260). Submit either electronic or written comments on the risk assessment by October 27, 2015. SUMMARY: Food and Drug Administration ACTION: Notice; extension of comment period. DEPARTMENT OF HEALTH AND HUMAN SERVICES AGENCY: Food and Drug Administration, PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 You may submit comments by any of the following methods: ADDRESSES: Electronic Submissions Submit electronic comments in the following way: • Federal eRulemaking Portal: http:// www.regulations.gov. Follow the instructions for submitting comments. Written Submissions Submit written submissions in the following ways: • Mail/Hand delivery/Courier (for paper submissions): Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. Instructions: All submissions received must include the Docket No. FDA– 2015–N–1305. All comments received may be posted without change to http:// www.regulations.gov, including any personal information provided. For additional information on submitting comments, see the ‘‘Comments’’ heading of the SUPPLEMENTARY INFORMATION section of this document. Docket: For access to the docket to read background documents or comments received, go to http:// www.regulations.gov and insert the docket number(s), found in brackets in the heading of this document, into the ‘‘Search’’ box and follow the prompts and/or go to the Division of Dockets Management, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. FOR FURTHER INFORMATION CONTACT: Jane Van Doren, Center for Food Safety and Applied Nutrition (HFS–005), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740, 240– 402–2927. SUPPLEMENTARY INFORMATION: I. Background In the Federal Register of April 30, 2015, FDA published a notice announcing the availability of a risk assessment entitled ‘‘Multicriteria-Based Ranking Model for Risk Management of Animal Drug Residues in Milk and Milk Products,’’ with a 90-day comment period to request comments on the risk assessment. We received a request for a 90-day extension of the comment period for the risk assessment. The request conveyed concern that the current 90-day comment period does not allow sufficient time to develop meaningful or thoughtful comments to the risk assessment. FDA has considered the request and is extending the comment period for the risk assessment for 90 days, until October 27, 2015. We believe that a 90- E:\FR\FM\30JYN1.SGM 30JYN1 Federal Register / Vol. 80, No. 146 / Thursday, July 30, 2015 / Notices day extension allows adequate time for interested persons to submit comments. II. Request for Comments Interested persons may submit either electronic comments regarding this document to http://www.regulations.gov or written comments to the Division of Dockets Management (see ADDRESSES). It is only necessary to send one set of comments. Identify comments with the docket number found in brackets in the heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday, and will be posted to the docket at http:// www.regulations.gov. III. Electronic Access Persons with access to the Internet may obtain the risk assessment at http:// www.fda.gov/Food/ FoodScienceResearch/ RiskSafetyAssessment/ucm443549.htm. Dated: July 24, 2015. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2015–18668 Filed 7–29–15; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2010–N–0155] Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Veterinary Feed Directive AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that a collection of information entitled ‘‘Veterinary Feed Directive’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE–14526, Silver Spring, MD 20993–0002, PRAStaff@ fda.hhs.gov. Lhorne on DSK7TPTVN1PROD with NOTICES SUMMARY: On May 19, 2015, the Agency submitted a proposed collection of information entitled ‘‘Veterinary Feed Directive’’ to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not SUPPLEMENTARY INFORMATION: VerDate Sep<11>2014 14:54 Jul 29, 2015 Jkt 235001 required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0363. The approval expires on July 31, 2018. A copy of the supporting statement for this information collection is available on the Internet at http://www.reginfo.gov/ public/do/PRAMain. Dated: July 24, 2015. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2015–18650 Filed 7–29–15; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Proposed Collection; 60 Day Comment Request Conference, Meeting, Workshop, and Poster Session Registration Generic Clearance (OD) Summary: In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the National Institutes of Health (NIH), Office of the Director (OD), will publish periodic summaries of proposed projects to the Office of Management and Budget (OMB) for review and approval. Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. To Submit Comments and for Further Information: To obtain a copy of the data collection plans and instruments, submit comments in writing, or request more information on the proposed project, contact: Ms. Mikia P. Currie, Program Analyst, Office of Policy for PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 45541 Extramural Research Administration, 6705 Rockledge Drive, Suite 350, Bethesda, Maryland 20892, or call a non-toll-free number 301–435–0941 or Email your request, including your address to curriem@mail.nih.gov. Formal requests for additional plans and instruments must be requested in writing. Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. Proposed Collection: Conference, Meeting, Workshop, and Poster Session Registration Generic Clearance (OD), 0925–New, National Institutes of Health (NIH), Office of the Director (OD). Need and Use of Information Collection: The information collections encompassed by this generic clearance will allow the NIH to select the most appropriate participants for non-grantee activities sponsored, organized, and run by the NIH staff, according to the type and purpose of the activity. For example, the NIH may develop an application process or information collection to select a limited number of researchers to participate in a poster session, identify speakers and panelists with desired expertise on a specific topic to be covered at a meeting, or determine which researchers would most likely benefit from a training course or other opportunity. For the NIH to plan and conduct activities that are timely for participants and their fields of research, it is often necessary for such information to be collected with a relatively short turnaround time. In general, submitted abstracts or other application materials will be reviewed by an internal NIH committee responsible for planning the activities. This committee will be responsible for selecting and notifying participants. The information collected for these activities generally includes title, author(s), institution/organization, poster size, character limitations along with other requirements. This information is necessary to identify attendees as eligible for poster presentations, to present their research, speak on panels, and discuss innovative approaches to science and technology to their peers. The registration form collects information from interested parties necessary to register them for a workshop. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 8,500. E:\FR\FM\30JYN1.SGM 30JYN1

Agencies

[Federal Register Volume 80, Number 146 (Thursday, July 30, 2015)]
[Notices]
[Pages 45540-45541]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-18668]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2015-N-1305]


Multicriteria-Based Ranking Model for Risk Management of Animal 
Drug Residues in Milk and Milk Products; Extension of Comment Period

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; extension of comment period.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or we) is extending the 
comment period for the risk assessment entitled ``Multicriteria-Based 
Ranking Model for Risk Management of Animal Drug Residues in Milk and 
Milk Products.'' A notice of the availability of the risk assessment 
and our request for comments appeared in the Federal Register of April 
30, 2015. We initially established July 29, 2015, as the deadline for 
the submission of requested comments that can help improve the ranking 
model approach, including the specific criteria, scoring, and weighting 
scheme; the scientific data and assumptions used to inform scoring used 
in the model; the selection of animal drugs evaluated; and the clarity 
and the transparency of the risk assessment. We are taking this action 
in response to a request for an extension to allow interested persons 
additional time to submit comments.

DATES: FDA is extending the comment period on the risk assessment whose 
availability we announced in a notice published on April 30, 2015 (80 
FR 24260). Submit either electronic or written comments on the risk 
assessment by October 27, 2015.

ADDRESSES: You may submit comments by any of the following methods:

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: http://www.regulations.gov. 
Follow the instructions for submitting comments.

Written Submissions

    Submit written submissions in the following ways:
     Mail/Hand delivery/Courier (for paper submissions): 
Division of Dockets Management (HFA-305), Food and Drug Administration, 
5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
    Instructions: All submissions received must include the Docket No. 
FDA-2015-N-1305. All comments received may be posted without change to 
http://www.regulations.gov, including any personal information 
provided. For additional information on submitting comments, see the 
``Comments'' heading of the SUPPLEMENTARY INFORMATION section of this 
document.
    Docket: For access to the docket to read background documents or 
comments received, go to http://www.regulations.gov and insert the 
docket number(s), found in brackets in the heading of this document, 
into the ``Search'' box and follow the prompts and/or go to the 
Division of Dockets Management, 5630 Fishers Lane, Rm. 1061, Rockville, 
MD 20852.

FOR FURTHER INFORMATION CONTACT: Jane Van Doren, Center for Food Safety 
and Applied Nutrition (HFS-005), Food and Drug Administration, 5100 
Paint Branch Pkwy., College Park, MD 20740, 240-402-2927.

SUPPLEMENTARY INFORMATION: 

I. Background

    In the Federal Register of April 30, 2015, FDA published a notice 
announcing the availability of a risk assessment entitled 
``Multicriteria-Based Ranking Model for Risk Management of Animal Drug 
Residues in Milk and Milk Products,'' with a 90-day comment period to 
request comments on the risk assessment.
    We received a request for a 90-day extension of the comment period 
for the risk assessment. The request conveyed concern that the current 
90-day comment period does not allow sufficient time to develop 
meaningful or thoughtful comments to the risk assessment.
    FDA has considered the request and is extending the comment period 
for the risk assessment for 90 days, until October 27, 2015. We believe 
that a 90-

[[Page 45541]]

day extension allows adequate time for interested persons to submit 
comments.

II. Request for Comments

    Interested persons may submit either electronic comments regarding 
this document to http://www.regulations.gov or written comments to the 
Division of Dockets Management (see ADDRESSES). It is only necessary to 
send one set of comments. Identify comments with the docket number 
found in brackets in the heading of this document. Received comments 
may be seen in the Division of Dockets Management between 9 a.m. and 4 
p.m., Monday through Friday, and will be posted to the docket at http://www.regulations.gov.

III. Electronic Access

    Persons with access to the Internet may obtain the risk assessment 
at http://www.fda.gov/Food/FoodScienceResearch/RiskSafetyAssessment/ucm443549.htm.

    Dated: July 24, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-18668 Filed 7-29-15; 8:45 am]
 BILLING CODE 4164-01-P